Patients with HS are at an increased risk of anxiety disorders.

Older adults taking antihypertensive drugs are at an increased risk of eczematous dermatitis.

The visibility of a skin disorder is directly linked to stigma including bullying.

Hidradenitis suppurativa patients are at higher risk for respiratory diseases.

There are significant delays in diagnosis and low implementation rates for treatment for HS.

Lutikizumab 300 mg was shown to be more effective than placebo in HS patients.

Clinicians are being urged to consider rat bite fever (RBF) in children presenting with symptoms such as fever, arthralgias, and skin...

According to a recent study, there is a high prevalence of HS in Finland among patients in their 30s.